Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cyberdyne
Tsukuba City, Ibaraki Prefecture, Japancyberdyne.jp ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Cyberdyne’s HAL® exoskeleton is commercially available in over 20 countries and has received regulatory approvals including FDA clearance in the US. Clinical use focuses on improving mobility and neuroregeneration in patients with spinal cord injuries, stroke, or neuromuscular disorders. Combined therapies with drugs and regenerative medicine are under research at their innovation bases.
- Therapeutic areas
- Neurology
- Modalities
- DeviceCell therapy (via partnerships/investments)Small molecule (via partnerships/investments)
- Industry
- Assistive Medical Devices
02
Partnerships
Development Center for Biotechnology (DCB), TaiwanFu Jen Catholic University & HospitalUniversity of Tsukuba/Cybernics Research CenterGAIA BioMedicine Inc. – capital/business alliance focused on cell therapy/cancer immunotherapyJameel Health – distribution/training partnership in Middle East/GCC region
Beyond the preview
Go deeper on Cyberdyne.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cyberdyne.